19.53USD-7.62%Mkt Cap: 535.23M USDP/E: —Last update: 2026-06-01
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VE…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap535.23M USD
Enterprise Value502.56M USD
Revenue (TTM)11.88M USD
Gross Profit11.88M USD
Net Income (TTM)-153.94M USD
Revenue/Share0.5900 USD
Last Price19.53 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees55
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINIE0004LIBFM2
Valuation
P/E (Trailing)—
P/E (Forward)-7.02
PEG—
EV/EBITDA—
EV/Revenue42.29
P/S47.92
P/B3.82
EPS (TTM)-5.88
EPS (Forward)-2.94
52W Range
8.72058% of range27.41
52W High27.41 USD
52W Low8.720 USD
Profitability
Gross Margin100.00%
Oper. Margin-2380.08%
EBITDA Margin0.00%
Profit Margin-1419.61%
ROE-75.83%
ROA-64.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-71.53M USD
CapEx (TTM)72.92M USD
FCF Margin—
FCF Yield—
Net Debt-187.62M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.01
Current Ratio13.78
Quick Ratio13.33
Book Value/Sh5.412 USD
Cash/Share5.693 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJun 16, 2025
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)30.29 USD
Target Range22.00 USD – 35.00 USD
# Analysts7
Ownership
Shares Out.27.57M
Float14.60M
Insiders5.81%
Institutions96.16%
Short Interest
Short Ratio9.3d
Short % Float24.03%
Short % Out.10.52%
Shares Short2.90M
Short (prev mo.)2.23M
Technical
SMA 5018.84 (+3.6%)
SMA 20013.98 (+39.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)304.79K
Avg Vol (10d)264.85K
Technical Indicators
RSI (14)55.8
MACD0.4110
MACD Signal0.2767
MACD Hist.+0.1343
BB Upper21.86 USD
BB Middle19.36 USD
BB Lower16.85 USD
BB Width25.90%
ATR (14)2.079 USD
Vol Ratio (20d)0.99x